Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
APVO compared with BNGO: revenue, margins and what each company keeps, and the suppliers and customers both name
APVO
Aptevo Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
BNGO
Bionano Genomics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
APVO
Aptevo Therapeutics Inc.
vs
BNGO
Bionano Genomics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only APVO
2
—
Alligator Bioscience AB
unlisted
supplier
—
Open Monoclonal Technology
unlisted
supplier
Shared
0
No disclosed counterparties: BNGO.
Only BNGO
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
APVO
Aptevo Therapeutics Inc.
Change
1.35
0.00%
Mkt cap
$2.4M
Revenue
—
Revenue
—
BNGO
Bionano Genomics, Inc.
Change
1.17
▲
+0.86%
Regular session
Nov 3 '26
Mkt cap
$13.5M
Revenue
$8M
Q2 FY26
Revenue
$29M
FY25
vs
Compare
Regular session
Nov 3 '26
APVO
Aptevo Therapeutics Inc.
vs
BNGO
Bionano Genomics, Inc.
1.35
0.00%
Price
1.17
▲
+0.86%
$2.4M
Mkt cap
$13.5M
—
Revenue
$8M
Q2 FY26
—
Revenue
$29M
FY25
Change
Change
APVO
1.35
0.00%
vs
BNGO
1.17
▲
+0.86%
Regular session
Nov 3 '26